Skip to main content

Peer Review reports

From: Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing

Original Submission
18 Jul 2018 Submitted Original manuscript
4 Sep 2018 Reviewed Reviewer Report - Alessandro Lagana
16 Sep 2018 Reviewed Reviewer Report - Lijun Cheng
19 Oct 2018 Author responded Author comments - Grace Dy
Resubmission - Version 2
19 Oct 2018 Submitted Manuscript version 2
13 Nov 2018 Reviewed Reviewer Report - Alessandro Lagana
20 Nov 2018 Reviewed Reviewer Report - Takahiko Koyama
7 Dec 2018 Author responded Author comments - Grace Dy
Resubmission - Version 3
7 Dec 2018 Submitted Manuscript version 3
12 Dec 2018 Reviewed Reviewer Report - Takahiko Koyama
21 Dec 2018 Reviewed Reviewer Report - Alessandro Lagana
4 Jan 2019 Author responded Author comments - Grace Dy
Resubmission - Version 4
4 Jan 2019 Submitted Manuscript version 4
Publishing
10 Jan 2019 Editorially accepted
18 Jan 2019 Article published 10.1186/s12911-019-0743-x

You can find further information about peer review here.

Back to article page